Generic Ezallor Availability
Last updated on Jun 11, 2025.
Ezallor is a brand name of rosuvastatin, approved by the FDA in the following formulation(s):
EZALLOR SPRINKLE (rosuvastatin calcium - capsule;oral)
-
Manufacturer: SUN PHARM
Approval date: December 18, 2018
Strength(s): EQ 5MG BASE (discontinued) [RLD], EQ 10MG BASE (discontinued) [RLD], EQ 20MG BASE (discontinued) [RLD], EQ 40MG BASE (discontinued) [RLD]
All of the above formulations have been discontinued.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ezallor. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: Generic Drug FAQ.
Related patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
-
Stable multiparticulate pharmaceutical composition of rosuvastatin
Patent 10,413,543
Issued: September 17, 2019
Inventor(s): Dharmadikari Nitin Bhalachandra & Zala Yashoraj & Gadkari Ashwini
Assignee(s): SUN PHARMA ADVANCED RESEARCH COMPANY LTD.A stable multi-particulate pharmaceutical composition comprising pellets, the pellets comprising a mixture of rosuvastatin or its pharmaceutically acceptable salts as a sole active ingredient, one or more osmotic release modifiers and one or more stabilizers.
Patent expiration dates:
- February 12, 2036✓
- February 12, 2036
More about Ezallor (rosuvastatin)
- Ezallor consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Imprints, shape & color data
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: statins
- Breastfeeding
- En español
Related treatment guides
Related/similar drugs
Lipitor
Lipitor is used to treat high cholesterol. Learn about side effects, interactions and indications.
Crestor
Crestor (rosuvastatin) is used to treat high cholesterol and high triglycerides in the blood ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Zetia
Zetia (ezetimibe) is used to treat high cholesterol. Includes Zetia side effects, interactions and ...
Zocor
Zocor (simvastatin) reduces low-density lipoprotein cholesterol and total cholesterol in the blood ...
Mevacor
Mevacor is used for high cholesterol, high cholesterol, familial heterozygous ...
Colesevelam
Colesevelam is used for diarrhea, chronic, high cholesterol, hyperlipoproteinemia ...
Niacin
Niacin is used to lower cholesterol and triglycerides. Learn about side effects, interactions and ...
Lovastatin
Lovastatin is used for high cholesterol, high cholesterol, familial heterozygous ...
Simvastatin
Simvastatin (Zocor) is a cholesterol-lowering medication that blocks the production of cholesterol ...
Glossary
| Term | Definition |
|---|---|
| Drug Patent | A drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation. |
| Drug Exclusivity | Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant. |
| RLD | A Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.